↓ Skip to main content

Risk of Rectal Cancer After Colectomy for Patients With Ulcerative Colitis: A National Cohort Study

Overview of attention for article published in Clinical Gastroenterology and Hepatology, December 2016
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

twitter
14 X users

Citations

dimensions_citation
57 Dimensions

Readers on

mendeley
86 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Risk of Rectal Cancer After Colectomy for Patients With Ulcerative Colitis: A National Cohort Study
Published in
Clinical Gastroenterology and Hepatology, December 2016
DOI 10.1016/j.cgh.2016.11.036
Pubmed ID
URN
urn:nbn:se:liu:diva-138873
Authors

Maie Abdalla, Kalle Landerholm, Peter Andersson, Roland E. Andersson, Pär Myrelid

Abstract

Patients with ulcerative colitis (UC) have an increased risk of rectal cancer, so reconstruction with an ileal pouch anal anastomosis (IPAA) is generally preferred to an ileo-rectal anastomosis (IRA) after subtotal colectomy. Similarly, completion proctectomy is recommended for patients with ileostomy and diverted rectum, although this approach has been questioned because anti-inflammatory agents might reduce cancer risk. We performed a national cohort study in Sweden to assess the risk of rectal cancer in patients with UC who have an IRA, IPAA, or diverted rectum after subtotal colectomy. We collected data from the Swedish National Patient Register for a cohort of 5886 patients with UC who underwent subtotal colectomy with an IRA, IPAA, or diverted rectum from 1964 through 2010. Patients who developed rectal cancer were identified from the Swedish National Cancer Register. Risk of rectal cancer was compared between this cohort and the general population by standardized incidence ratio analysis. Rectal cancer occurred in 20/1112 patients (1.8%) who received IRA, 1/1796 patients (0.06%) who received an IPAA, and 25/4358 patients (0.6 %) with a diverted rectum. Standardized incidence ratios for rectal cancer were 8.7 in patients with an IRA, 0.4 in patients with an IPAA, and 3.8 in patients with a diverted rectum. Risk factors for rectal cancer were primary sclerosing cholangitis in patients with an IRA (hazard ratio, 6.12), and colonic severe dysplasia or cancer prior to subtotal colectomy in patients with a diverted rectum (hazard ratio, 3.67). In an analysis of Swedish National Patient Register, we found that risk for rectal cancer after colectomy in patients with UC is low, in relative and absolute terms, after reconstruction with an IPAA. IRA and diverted rectum are associated with an increased risk of rectal cancer, compared with the general population, but the absolute risk is low. Patients and their health care providers should consider these findings in making decisions to leave the rectum intact, perform complete proctectomy, or reconstruct the colon with an IRA or IPAA.

X Demographics

X Demographics

The data shown below were collected from the profiles of 14 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 86 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 86 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 12 14%
Researcher 10 12%
Other 9 10%
Student > Master 8 9%
Student > Postgraduate 6 7%
Other 20 23%
Unknown 21 24%
Readers by discipline Count As %
Medicine and Dentistry 45 52%
Psychology 4 5%
Biochemistry, Genetics and Molecular Biology 2 2%
Computer Science 2 2%
Nursing and Health Professions 1 1%
Other 5 6%
Unknown 27 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 December 2019.
All research outputs
#4,300,481
of 25,371,288 outputs
Outputs from Clinical Gastroenterology and Hepatology
#1,719
of 4,671 outputs
Outputs of similar age
#77,525
of 422,577 outputs
Outputs of similar age from Clinical Gastroenterology and Hepatology
#22
of 77 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,671 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 16.9. This one has gotten more attention than average, scoring higher than 63% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 422,577 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 77 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.